Showing 631-640 of 1225 results for "".
The Art and Science of Referrals
https://modernod.com/topics/business/the-art-and-science-of-referrals/39071/Ensure that your patients receive the care they need—even when it falls outside of your practice pattern or capability.Road Map for Success: How to Manage Dry Eye in Your Practice
https://modernod.com/topics/ocular-surface/road-map-for-successhow-to-manage-dry-eye-in-your-practice/37960/Pearls for managing dry eye disease for seasoned veterans and novices alike.Dry Eye Cases From a Collaborative Clinic
https://modernod.com/topics/cataractrefractive-surgery/dry-eye-cases-from-a-collaborative-clinic/39163/Using all of the tools in the dry eye toolbox.Evolving Concepts in Anterior Segment Outcomes: Tackling Ocular Surface Disease, Comanaging Premium IOL Patients, and Identifying New Keratoconus Treatments
https://modernod.com/topics/ocular-surface/evolving-concepts-in-anterior-segment-outcomes-tackling-ocular-surface-disease-comanaging-premium-iol-patients-and-identifying-new-keratoconus-treatments/38100/22. Prescribe Change and CONNECT with Patients
https://modernod.com/podcasts/four-eyes/22-prescribe-change-and-connect-with-patients/36972/We sit down with Dr. Steve Vargo to discuss his new book, Prescribing Change. The book's intention is to develop methods for optometrists to share information with their patients and have them ACT on it. We review his genius CONNECT method that navigates making connections with patients and influencTFOS DEWS III Published
https://modernod.com/podcasts/eyewire-news-the-podcast/tfos-dews-iii-published/37089/The Tear Film and Ocular Surface Society publishes the third installment of the TFOS DEWS report; J&J launches the Tecnis Odyssey presbyopia-correcting IOL in Europe, the Middle East, and Canada; and Harrow acquires the exclusive US commercial rights to postoperative inflammation and pain drug B2. Myopia Control: Treatment Options and Upcoming Research
https://modernod.com/podcasts/four-eyes/2-myopia-control-treatment-options-and-upcoming-research/36952/We review treatment options related to myopia control including the new FDA approved lenses MiSight 1-Day by CooperVision, and share upcoming research in this area from Keyur Savla, BOptom and Celia Gong, OD.Resources:1. Review of Optometry Article on Myopia Treatments: https://www.reviewofoptometryBilling and Coding for the Optometric Practice
https://modernod.com/topics/glaucoma/billing-and-coding-for-the-optometric-practice/38488/Key takeaways from the optometric business management session at the MOD Live 2022 meeting held in Nashville, Tennessee.GA Case Compendium: Simultaneous Development of Geographic Atrophy and Wet AMD in a Patient Lost to Follow-up
https://modernod.com/resources/geographic-atrophy-case-compendium/simultaneous-development-of-geographic-atrophy-and-wet-amd-in-a-patient-lost-to-follow-up/39243/Ocular Effects of Pituitary Tumor
https://modernod.com/topics/imagingdiagnostics/ocular-effects-of-pituitary-tumor/38974/Visual symptoms may be the first clues that a patient has developed this pituitary adenoma.